Amgen Inc
(FRA:AMG)
€
283.45
-18.25 (-6.05%)
Market Cap: 150.69 Bil
Enterprise Value: 198.90 Bil
PE Ratio: 38.26
PB Ratio: 21.34
GF Score: 90/100 
Amgen Inc at Cowen Immuno-Oncology Next Summit (Virtual) Transcript
Nov 15, 2021 / 07:15PM GMT
Release Date Price:
€183.96
(-0.31%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
All right. Well, good afternoon, everybody, and thank you for joining us again at this year's IO Summit. I'm Yaron Werber from the biotech team at Cowen. With me here today is my colleague, Gabe Schneider, and it's a great pleasure for both of us to co-moderate this session with Amgen.
Today, we have David Reese, who's EVP of R&D; and also Jean-Charles Soria, who's SVP, Global Development Oncology. So gentlemen, thank you so much for joining us. Really appreciate it.
David M. Reese
Amgen Inc. - EVP of Research & Development
Great to see you, Yaron.
Jean;Charles Soria
Amgen Inc. - SVP of Research & Development
Our pleasure.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
There's a lot to talk about. So we are focusing more on the IO pipeline,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers